Abstract
Obstetrical hemorrhage is the most common cause of maternal mortality worldwide. Together with adequate surgical control and judicious transfusion of blood products, the use of pharmacological agents (e.g., tranexamic acid) and clotting factor concentrates (e.g., fibrinogen concentrates and prothrombin complex concentrates) results in improved hemostasis and decreased bleeding-associated mortality. Guidance in the administration of these agents with the use of viscoelastic testing will likely become standard of care in the near future.
Original language | English (US) |
---|---|
Pages (from-to) | 22-26 |
Number of pages | 5 |
Journal | Seminars in Perinatology |
Volume | 43 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2019 |
Keywords
- Post partum hemorrhage
- fibrinogen
- pregnancy
- transfusion
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Obstetrics and Gynecology